Rare Disease Report

Educating Payors About Rare Diseases

NOVEMBER 10, 2015
Richard Peters, MD, PhD

Richard Peters, MD, PhD, head of the global rare disease business unit at Genzyme talks about the importance of educating payors about rare diseases and orphan drugs.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.